US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vyome Holdings, Inc.

2.16

-0.0448-2.03%

Post-market: 2.160.00000.00%16:10 EDT

Volume:7K

Turnover:15.69K

Market Cap:15.16M

PE:-1.34

High:2.23

Open:2.16

Low:2.15

Close:2.21

52wk High:9.56

52wk Low:1.75

Shares:7.02M

Float Shares:1.54M

Volume Ratio:1.66

T/O Rate:0.46%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6111

EPS(LYR):-4.7480

ROE:-999.17%

ROA:-48.79%

PB:2.51

PE(LYR):-0.45

Loading ...

Overview Company News Filings

Vyome names Jerry Leonard as CFO

Vyome - Appoints Jerry Leonard as CFO on August 27, 2026 - SEC Filing

THOMSON REUTERS

Vyome Holdings Appoints Jerry Leonard as CFO Effective Sept. 1

Sweden's Modus Therapeutics Narrows Q2 Net Loss, Extends Financing

Biopharma Firm Vyome Holdings Posts Q2 Net Loss

Vyome Holdings Inc Q2 EPS USD 0.1

THOMSON REUTERS

Vyome Q2 FY26 Net Loss Narrows to $720,000; Operating Expenses Rise to $874,000

Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead Vt-1953 Program, Pipeline Expansion and Strong Balance Sheet

THOMSON REUTERS

Press Release: Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet

Vyome Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Vyome Net Loss Widens to $719,683 in Q2 FY26; Revenue Falls to $26,955

Vyome Holdings Inc Expected to Post a Loss of 19 Cents a Share - Earnings Preview

Vyome announces CNIPA granted patent covering formula related to besifloxacin

Vyome Wins China Patent for Besifloxacin Gel in Inflammatory Acne

Vyome Granted Chinese Patent Strengthening Immuno-inflammation Portfolio

THOMSON REUTERS

Vyome net loss widens to $985,521 in Q1 FY26

Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet

THOMSON REUTERS

Vyome - Q1 2026 Net Loss Attributable to Common Shareholders $963,000 or $0.15 per Share

THOMSON REUTERS

Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Vyome Holdings (HIND)

Vyome Holdings Q1 FY26 net loss widens to $985,521; revenue drops to $31,591

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/HIND/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HIND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIND\",,,,,undefined,":{"symbol":"HIND","market":"US","secType":"STK","nameCN":"Vyome Holdings, Inc.","latestPrice":2.1602,"timestamp":1788206400000,"preClose":2.205,"halted":0,"volume":7176,"hourTrading":{"tag":"盘后","latestPrice":2.1602,"preClose":2.1602,"latestTime":"16:10 EDT","volume":6,"amount":12.9,"timestamp":1788207004369,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.020317460317460293,"floatShares":1543899,"shares":7018528,"eps":-1.611126,"marketStatus":"Closed","change":-0.0448,"latestTime":"08-31 16:00:00 EDT","open":2.16,"high":2.23,"low":2.1512,"amount":15685,"amplitude":0.035737,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.611126,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"listingDate":1475726400000,"exchange":"NASDAQ","adjPreClose":2.205,"preHourTrading":{"tag":"盘前","latestPrice":2.16,"preClose":2.205,"latestTime":"07:00 EDT","volume":1,"amount":2.16,"timestamp":1788174000222,"change":-0.045,"changeRate":-0.020408,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.1602,"preClose":2.1602,"latestTime":"16:10 EDT","volume":6,"amount":12.9,"timestamp":1788207004369,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.66165},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIND\",,,,,undefined,":{"symbol":"HIND","floatShares":1543899,"roa":"-48.79%","roe":"-999.17%","lyrEps":-4.747979,"volumeRatio":1.66165,"shares":7018528,"dividePrice":0,"high":2.23,"amplitude":0.035737,"preClose":2.205,"low":2.1512,"week52Low":1.75,"pbRate":"2.51","psRate":"116.87","week52High":9.56,"institutionHeld":0,"latestPrice":2.1602,"eps":-1.611126,"divideRate":0,"volume":7176,"delay":0,"ttmEps":-1.611126,"open":2.16,"prevYearClose":3.44,"prevWeekClose":2.205,"prevMonthClose":2.115,"prevQuarterClose":2.15,"fiveDayClose":2.242,"twentyDayClose":2.165,"sixtyDayClose":2.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"HIND","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2026-06-03","symbol":"HIND","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1780459200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2026-05-12","symbol":"HIND","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2026-03-18","symbol":"HIND","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773806400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-14","symbol":"HIND","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":-3.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIND\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1778126400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HIND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HIND","date":"2026-08-28","current":-1.340801,"percent":0.827451,"low":-23.816091,"twenty":-10.790143,"median":-1.552627,"eighty":-1.38689,"high":-0.001601,"avg":-5.364341,"sd":7.376362,"marketCap":15510946},"quantilePoints":[{"date":"2025-08-22","current":-12.854344,"twenty":-12.392244,"median":-11.699095,"eighty":-11.005946,"marketCap":20748595},{"date":"2025-08-29","current":-11.259279,"twenty":-13.22027,"median":-12.854344,"eighty":-11.500884,"marketCap":18173952},{"date":"2025-09-05","current":-9.124707,"twenty":-13.182739,"median":-11.259279,"eighty":-10.03366,"marketCap":14728473},{"date":"2025-09-12","current":-0.001997,"twenty":-12.854344,"median":-10.288753,"eighty":-0.00213,"marketCap":2910},{"date":"2025-09-19","current":-0.001751,"twenty":-12.467306,"median":-9.124707,"eighty":-0.001933,"marketCap":2551},{"date":"2025-09-26","current":-20.664803,"twenty":-13.499407,"median":-10.288753,"eighty":-0.001997,"marketCap":30109879},{"date":"2025-10-03","current":-20.473816,"twenty":-20.473816,"median":-11.259279,"eighty":-0.002098,"marketCap":29831599},{"date":"2025-10-10","current":-21.00858,"twenty":-21.00858,"median":-13.018541,"eighty":-0.002106,"marketCap":30610783},{"date":"2025-10-17","current":-19.327894,"twenty":-20.855791,"median":-13.499407,"eighty":-0.00213,"marketCap":28161920},{"date":"2025-10-24","current":-20.850495,"twenty":-20.850495,"median":-19.346992,"eighty":-0.002143,"marketCap":30380443},{"date":"2025-10-31","current":-21.039016,"twenty":-20.850495,"median":-19.786263,"eighty":-9.124707,"marketCap":30655130},{"date":"2025-11-07","current":-21.340651,"twenty":-21.039016,"median":-20.206435,"eighty":-10.010203,"marketCap":31094630},{"date":"2025-11-14","current":-18.588235,"twenty":-21.00858,"median":-20.168237,"eighty":-10.03366,"marketCap":27084192},{"date":"2025-11-21","current":-17.984966,"twenty":-21.00858,"median":-20.037322,"eighty":-10.543846,"marketCap":26205192},{"date":"2025-11-28","current":-3.129419,"twenty":-20.886349,"median":-19.767164,"eighty":-7.929274,"marketCap":29238478},{"date":"2025-12-05","current":-3.075047,"twenty":-20.851554,"median":-19.327894,"eighty":-3.104045,"marketCap":28730474},{"date":"2025-12-12","current":-2.881724,"twenty":-20.850495,"median":-18.663643,"eighty":-3.026716,"marketCap":26924236},{"date":"2025-12-19","current":-2.342231,"twenty":-20.820331,"median":-18.362009,"eighty":-2.975968,"marketCap":21883703},{"date":"2025-12-26","current":-2.271547,"twenty":-20.790168,"median":-17.381696,"eighty":-2.665444,"marketCap":21223297},{"date":"2026-01-02","current":-2.078224,"twenty":-20.744922,"median":-13.229653,"eighty":-2.363376,"marketCap":19417059},{"date":"2026-01-09","current":-2.072183,"twenty":-20.685727,"median":-12.660825,"eighty":-2.260673,"marketCap":19360614},{"date":"2026-01-16","current":-1.866777,"twenty":-20.618426,"median":-10.790143,"eighty":-2.104806,"marketCap":17441486},{"date":"2026-01-23","current":-1.761053,"twenty":-20.541319,"median":-10.03366,"eighty":-2.062517,"marketCap":16453700},{"date":"2026-01-30","current":-1.292849,"twenty":-20.511156,"median":-6.2932,"eighty":-1.940481,"marketCap":12079217},{"date":"2026-02-06","current":-1.38951,"twenty":-20.503688,"median":-3.129419,"eighty":-1.87886,"marketCap":12982336},{"date":"2026-02-13","current":-1.576792,"twenty":-20.469996,"median":-3.093171,"eighty":-1.729639,"marketCap":14732129},{"date":"2026-02-20","current":-1.661371,"twenty":-20.454717,"median":-3.029737,"eighty":-1.661371,"marketCap":15522358},{"date":"2026-02-27","current":-2.029893,"twenty":-20.435747,"median":-3.008592,"eighty":-1.661371,"marketCap":18965499},{"date":"2026-03-06","current":-1.758033,"twenty":-20.359224,"median":-2.95875,"eighty":-1.667412,"marketCap":16425477},{"date":"2026-03-13","current":-1.4318,"twenty":-20.28493,"median":-2.791104,"eighty":-1.619082,"marketCap":13377450},{"date":"2026-03-20","current":-1.254087,"twenty":-20.244632,"median":-2.425601,"eighty":-1.576792,"marketCap":12869446},{"date":"2026-03-27","current":-1.504653,"twenty":-20.168237,"median":-2.342231,"eighty":-1.56471,"marketCap":15440761},{"date":"2026-04-02","current":-1.470457,"twenty":-20.080611,"median":-2.271547,"eighty":-1.552627,"marketCap":15089835},{"date":"2026-04-10","current":-1.573046,"twenty":-20.054657,"median":-2.19603,"eighty":-1.544169,"marketCap":16142614},{"date":"2026-04-17","current":-1.518332,"twenty":-20.027528,"median":-2.096348,"eighty":-1.529274,"marketCap":15581132},{"date":"2026-04-24","current":-1.545689,"twenty":-19.83321,"median":-2.075203,"eighty":-1.529274,"marketCap":15861873},{"date":"2026-05-01","current":-1.388384,"twenty":-19.755705,"median":-2.0601,"eighty":-1.503285,"marketCap":14247611},{"date":"2026-05-08","current":-1.43626,"twenty":-19.442486,"median":-1.999686,"eighty":-1.470457,"marketCap":14738908},{"date":"2026-05-15","current":-1.232791,"twenty":-19.335533,"median":-1.945315,"eighty":-1.456778,"marketCap":13475573},{"date":"2026-05-22","current":-1.431836,"twenty":-19.175104,"median":-1.918128,"eighty":-1.435375,"marketCap":15651317},{"date":"2026-05-29","current":-1.508885,"twenty":-18.898194,"median":-1.893963,"eighty":-1.43449,"marketCap":16493540},{"date":"2026-06-05","current":-1.476781,"twenty":-18.648562,"median":-1.87886,"eighty":-1.43626,"marketCap":16142614},{"date":"2026-06-12","current":-1.46394,"twenty":-18.475122,"median":-1.845633,"eighty":-1.431822,"marketCap":16002243},{"date":"2026-06-18","current":-1.399732,"twenty":-18.384631,"median":-1.759543,"eighty":-1.421213,"marketCap":15300391},{"date":"2026-06-26","current":-1.354786,"twenty":-18.211192,"median":-1.721785,"eighty":-1.4023,"marketCap":14809094},{"date":"2026-07-02","current":-1.444678,"twenty":-17.864312,"median":-1.691578,"eighty":-1.395484,"marketCap":15791688},{"date":"2026-07-10","current":-1.431836,"twenty":-16.605238,"median":-1.658351,"eighty":-1.395484,"marketCap":15651317},{"date":"2026-07-17","current":-1.406153,"twenty":-13.445456,"median":-1.607243,"eighty":-1.397164,"marketCap":15370576},{"date":"2026-07-24","current":-1.374049,"twenty":-13.22027,"median":-1.588875,"eighty":-1.395224,"marketCap":15019649},{"date":"2026-07-31","current":-1.290579,"twenty":-13.182739,"median":-1.586725,"eighty":-1.393311,"marketCap":14107241},{"date":"2026-08-07","current":-1.374049,"twenty":-12.854344,"median":-1.573046,"eighty":-1.388384,"marketCap":15019649},{"date":"2026-08-14","current":-1.340677,"twenty":-12.467306,"median":-1.565459,"eighty":-1.38689,"marketCap":15160020},{"date":"2026-08-21","current":-1.415158,"twenty":-11.259279,"median":-1.558668,"eighty":-1.38689,"marketCap":16002243},{"date":"2026-08-28","current":-1.37171,"twenty":-10.790143,"median":-1.552627,"eighty":-1.38689,"marketCap":15510946}],"updateTime":1788221177608},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIND\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663015954","title":"Vyome names Jerry Leonard as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015954","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015954?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:45","pubTimestamp":1787949914,"startTime":"0","endTime":"0","summary":"In a regulatory filing, the company stated, “On August 27, 2026, the board of directors of Vyome (HIND) Holdings appointed Jerry Leonard as the com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vyome-names-jerry-leonard-as-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vyome-names-jerry-leonard-as-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4007","HIND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663868015","title":"Vyome - Appoints Jerry Leonard as CFO on August 27, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2663868015","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663868015?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:37","pubTimestamp":1787949469,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P20B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIND","BK4007","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663130930","title":"Vyome Holdings Appoints Jerry Leonard as CFO Effective Sept. 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2663130930","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663130930?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:32","pubTimestamp":1787949146,"startTime":"0","endTime":"0","summary":"Vyome Holdings appoints Jerry Leonard as CFO effective Sept. 1Vyome Holdings appointed Jerry Leonard as chief financial officer, effective Sept. 1, 2026.Leonard will also serve as principal financial ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL7w8Wdj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4007","BK4167","BK4082","VSEE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662776063","title":"Sweden's Modus Therapeutics Narrows Q2 Net Loss, Extends Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2662776063","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662776063?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:10","pubTimestamp":1787724627,"startTime":"0","endTime":"0","summary":"Sweden's Modus Therapeutics narrows Q2 net loss, extends financingOverviewSweden biotech firm's Q2 net loss and loss per share narrowed from prior yearCompany raised about 9.5 mln SEK via warrant exer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N06F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4082","HIND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662573440","title":"Biopharma Firm Vyome Holdings Posts Q2 Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2662573440","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662573440?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:23","pubTimestamp":1787660603,"startTime":"0","endTime":"0","summary":"Biopharma firm Vyome Holdings posts Q2 net lossOverviewUS biopharmaceutical firm's Q2 net loss was $720,000, or $0.10 per shareCash and cash equivalents rose to $7.9 mln as of June 30, 2026Company adv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0C7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4082","HIND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662734675","title":"Vyome Holdings Inc Q2 EPS USD 0.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734675?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:11","pubTimestamp":1787659866,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nPLXSHHD46:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4082","HIND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662734384","title":"Vyome Q2 FY26 Net Loss Narrows to $720,000; Operating Expenses Rise to $874,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734384","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734384?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:03","pubTimestamp":1787659413,"startTime":"0","endTime":"0","summary":"Vyome Q2 FY26 net loss narrows to $720,000; operating expenses rise to $874,000Vyome Holdings posted a net loss attributable to common shareholders of USD 720,000, or USD 0.10 a share, for Q2 2026.Ope","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL91yd5X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4007","HIND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731705","title":"Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead Vt-1953 Program, Pipeline Expansion and Strong Balance Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662731705?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA7MZWDB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","HIND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662734825","title":"Press Release: Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734825","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734825?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659200,"startTime":"0","endTime":"0","summary":"including the proposed pivotal clinical study strategy for VT-1953;received the FDA's written response on the proposed clinical development. program during the second quarter; is incorporating the FDA's feedback,preparing the appropriate supporting package, and plans to continue its","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","LABU","BK4588","DBB","BK4082","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659958185","title":"Vyome Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659958185","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659958185?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:46","pubTimestamp":1786571203,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings SummaryVyome Holdings IncHIND.OQreported a quarterly adjusted loss of 10 cents per share for the quarter ended June 30.  The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N44929T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659818880","title":"Vyome Net Loss Widens to $719,683 in Q2 FY26; Revenue Falls to $26,955","url":"https://stock-news.laohu8.com/highlight/detail?id=2659818880","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659818880?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:33","pubTimestamp":1786566826,"startTime":"0","endTime":"0","summary":"Vyome net loss widens to $719,683 in Q2 FY26; revenue falls to $26,955Vyome Holdings posted a net loss of $719,683 for the three months ended June 30, 2026, widening from $308,760 a year earlier.Reven","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL9ywcM7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300485","BK4007","BK0046","BK0239","HIND","BK4082","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995167","title":"Vyome Holdings Inc Expected to Post a Loss of 19 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995167","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995167?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:32","pubTimestamp":1786393926,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc <HIND.OQ> expected to post a loss of19cents a share - Earnings PreviewVyome Holdings IncHIND.OQHIND.Ois expected to  report resultson August 12  for the period ending June 30 2026LSEG's mean analyst estimate for Vyome Holdings Inc is for a loss of 19 cents per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Vyome Holdings Inc is $11.50, about 432.4% above its last closing price of $2.16This summary was machine generated August 10 at 20:32 GMT.  All figures in US dollars unless otherwise stated.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N4471WE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4007","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648548296","title":"Vyome announces CNIPA granted patent covering formula related to besifloxacin","url":"https://stock-news.laohu8.com/highlight/detail?id=2648548296","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648548296?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:10","pubTimestamp":1782907837,"startTime":"0","endTime":"0","summary":"Vyome (HIND) announces that the China National Intellectual Property Administration, CNIPA, has granted a patent covering formulation and therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vyome-announces-cnipa-granted-patent-covering-formula-related-to-besifloxacin-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vyome-announces-cnipa-granted-patent-covering-formula-related-to-besifloxacin-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIND","BK4082","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648548824","title":"Vyome Wins China Patent for Besifloxacin Gel in Inflammatory Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2648548824","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648548824?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:02","pubTimestamp":1782907350,"startTime":"0","endTime":"0","summary":"Vyome wins China patent for besifloxacin gel in inflammatory acneVyome Holdings received a Chinese patent covering formulation and therapeutic-use claims for its besifloxacin topical gel program in in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL1N18xL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4007","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648654886","title":"Vyome Granted Chinese Patent Strengthening Immuno-inflammation Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2648654886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648654886?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:02","pubTimestamp":1782907333,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nFWN4330KX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","HIND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638169698","title":"Vyome net loss widens to $985,521 in Q1 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2638169698","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638169698?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:03","pubTimestamp":1779969828,"startTime":"0","endTime":"0","summary":"Vyome Holdings posted a net loss attributable to common shareholders of $963,000, or $0.15 per share, for Q1 ended March 31, 2026.Revenue fell to $31,591 from $198,581 a year earlier, while operating expenses jumped to $1.1 million from $353,417.Cash and cash equivalents climbed to $8.8 million from $5 million at Dec. 31, 2025, following a $5.29 million common-share sale.VT-1953 advanced toward pivotal-stage readiness with FDA discussions; an Orphan Drug Designation application was filed for malignant fungating wounds.Management highlighted a debt-free capital structure; VT-1953 Phase 2 data were presented at AACR 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL1HnTSd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HIND","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638986286","title":"Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2638986286","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638986286?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969607,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nTUA5JWQCX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4007","HIND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698401","title":"Vyome - Q1 2026 Net Loss Attributable to Common Shareholders $963,000 or $0.15 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698401?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969607,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nTUA5JWQCX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4082","HIND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636829826","title":"Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Vyome Holdings (HIND)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636829826","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636829826?lang=en_us&edition=fundamental","pubTime":"2026-05-20 23:30","pubTimestamp":1779291009,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT) and Vyome Holdings (HIND) with bulli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-medtronic-mdt-vyome-holdings-hind-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-medtronic-mdt-vyome-holdings-hind-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1989771016.USD","BK4588","BLSG","LU1116320901.HKD","MDT","BK4533","LU2028103732.USD","BK4581","IE00B42XCP33.USD","LU0265550946.USD","LU2023251221.USD","XBI","LU0976567544.SGD","LU0106261372.USD","LABU","LU1983299246.USD","LU1291159041.SGD","HIND","LU1023059063.AUD","LU0496365809.HKD","BK4082","LU0006306889.USD","LU0122379950.USD","LU1244550577.SGD","LU1244550221.USD","LU2112291526.USD","BK4137","LU1506573853.SGD","LU0072461881.USD","LU0432979614.USD","LU0070302665.USD","LU1989764664.SGD","LU0162691827.USD","LU0314106906.USD","LU0208291251.USD","LU0158827948.USD","IE00BQXX3F31.USD","LU0029874061.USD","LU2089984988.USD","BK4112","LU1061106388.HKD","IE000M9KFDE8.USD","IE00BVYPNW00.USD","BK4007","LU0211331839.USD","LU1244550494.USD","IE00B3T34201.USD","IE00BFXG1179.USD","IE00BQXX3D17.EUR","IE00B3PB1722.GBP","LU2468319806.SGD","LU0265550359.USD","IE00BDGV0183.EUR","LU1057294990.SGD","LU2089284900.SGD","LU0158827781.USD","LU2089283258.USD","BK4566","LU1116320737.USD","LU0211326755.USD","LU0128526141.USD","IE00BQXX3C00.GBP","LU1571399168.USD","LU1989764748.USD","LU0211326839.USD","LU2111349929.HKD","IE00BGHQF631.EUR","LU2271345857.HKD","BLSX","BK4585","LU0320765489.SGD","IE00BVYPNV92.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635124209","title":"Vyome Holdings Q1 FY26 net loss widens to $985,521; revenue drops to $31,591","url":"https://stock-news.laohu8.com/highlight/detail?id=2635124209","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635124209?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:04","pubTimestamp":1778616259,"startTime":"0","endTime":"0","summary":"Vyome Holdings posted a net loss of $985,521 for the three months ended March 31, 2026, widening from $293,974 a year earlier.Revenue fell 84.09% to $31,591, while operating loss widened to $1.13 million from $198,998.Research and development expense climbed to $666,405 from $90,268, due to scaling up regulatory consulting and CMC preparation work for VT-1953.Selling, general and administrative expense rose to $477,575 from $259,626 on higher legal, accounting and auditing fees tied to the merger, with stock-based compensation of $5,696.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval syst","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL92XcSx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HIND","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}]}}